Guru Ownership Trend
Guru Analysis for Praxis Precision Medicines, Inc. (PRAX)
Praxis Precision Medicines, Inc. (PRAX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $20.6 M.
Top institutional holders include Cliff Asness and John Hussman.
Institutional sentiment is currently Bearish. This is evidenced by a $156.38 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 103.5%. Conversely, John Hussman reduced exposure by 50.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Praxis Precision Medicines, Inc. (PRAX)
Major holders include Cliff Asness ($18.9 M), John Hussman ($1.35 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 62,856 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $156.38 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited PRAX. The total reported sell value was $165.99 M.
Yes, 0 managers opened new positions in PRAX, and 1 increased their existing holdings. The total reported buy value was $9.61 M.